You better believe it!/——/ Old fart![]()
Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
You better believe it!/——/ Old fart![]()
We all gotta pay the bills somehow. Have you ever considered buying a timeshare? I know a guy who can help.True, the Trumpian crowd leaves the stock pump and dumping to the Democrat crowd.
Un Luckyone , if we took his advice we would be still losing money, down to $24.80, so almost a $10 a share loss since unlucky one’s tip.ZLAB - A stock that you all should consider buying
ZLAB is a Chinese Bio-Pharma company that traded as high as 193.54 (4 years ago) and is now trading at 34.00 (with a low made 16 months ago at 13.48.
The stock went down because the company being a Bio-Pharma company developing new medicines, was always in the red (re earnings and expenses). Nonetheless, during this time, the company has been successful in developing new medicines that in some cases have now been designated by China as "innovative" and likely to become established as needed medicines for things like Cancer, when all phases have shown success.
Some 2 years ago (when the stock got down to the lows), it was because the company required additional funds for generating sales of its products. That is now mostly over as some of its medicines are now starting to be used.
This BioPharma company has a market capitalization of $4.07 billion dollars, meaning that it is the 23rd largest Biopharma company in China.
Here is an AI generated future outlook for the company:
ZLAB has a positive future outlook with analysts projecting strong revenue growth and potential profitability within the next few years. Analysts are optimistic about the company's growth prospects, citing its expanding commercial portfolio, strong pipeline, and strategic focus o both the Chinese and global markets.
Citi has a buy rating on the company with a 12-month price target of $66
Chart-wise, since the low was made back in April 2024, the chart shows a clear up channel with 4 weekly closing points showing the bottom of the channel being presently at 33.22. The top of the channel has 2 points on it, and it shows the top of the channel presently being around the $50, a level that should be reached within the next 2-4 months.
The stock is presently oversold, meaning it is ready to buy now.
A weekly close below 32.73 would break the bottom of the channel, meaning that a purchase around here would offer a risk of approximately $125, versus a profit potential of $3200 (per 100 shares).
In my opinion, this is a BUY here and now.
Good Luck to all of you.
But the wanker has been offering advice for YEARS!Un Luckyone , if we took his advice we would be still losing money, down to $24.80, so almost a $10 a share loss since unlucky one’s tip.

ZLAB - A stock that you all should consider buying
ZLAB is a Chinese Bio-Pharma company that traded as high as 193.54 (4 years ago) and is now trading at 34.00 (with a low made 16 months ago at 13.48.
The stock went down because the company being a Bio-Pharma company developing new medicines, was always in the red (re earnings and expenses). Nonetheless, during this time, the company has been successful in developing new medicines that in some cases have now been designated by China as "innovative" and likely to become established as needed medicines for things like Cancer, when all phases have shown success.
Some 2 years ago (when the stock got down to the lows), it was because the company required additional funds for generating sales of its products. That is now mostly over as some of its medicines are now starting to be used.
This BioPharma company has a market capitalization of $4.07 billion dollars, meaning that it is the 23rd largest Biopharma company in China.
Here is an AI generated future outlook for the company:
ZLAB has a positive future outlook with analysts projecting strong revenue growth and potential profitability within the next few years. Analysts are optimistic about the company's growth prospects, citing its expanding commercial portfolio, strong pipeline, and strategic focus o both the Chinese and global markets.
Citi has a buy rating on the company with a 12-month price target of $66
Chart-wise, since the low was made back in April 2024, the chart shows a clear up channel with 4 weekly closing points showing the bottom of the channel being presently at 33.22. The top of the channel has 2 points on it, and it shows the top of the channel presently being around the $50, a level that should be reached within the next 2-4 months.
The stock is presently oversold, meaning it is ready to buy now.
A weekly close below 32.73 would break the bottom of the channel, meaning that a purchase around here would offer a risk of approximately $125, versus a profit potential of $3200 (per 100 shares).
In my opinion, this is a BUY here and now.
Good Luck to all of you.
Yet another "wanker winner"!!!
LOL I took a free weekend at the Las Vegas Jockey Club back in the day with a friend. We just had to agree to listen to their timeshare sales pitch. Holy Shit, you want to talk about high pressure sales tactics! It was like being interrogated complete with the Good Cop/Bad Cop schtick.We all gotta pay the bills somehow. Have you ever considered buying a timeshare? I know a guy who can help.

.LOL I took a free weekend at the Las Vegas Jockey Club back in the day with a friend. We just had to agree to listen to their timeshare sales pitch. Holy Shit, you want to talk about high pressure sales tactics! It was like being interrogated complete with the Good Cop/Bad Cop schtick.![]()
I wish we'd have thought of that!.
Hubby and I did that once, a developer on the Deschutes River in Oregon. Checked in at the hotel and then at the development, then went and enjoyed our free dinner, had a nice evening looking at tourist stuff, had one night's stay at the hotel, and then ran up to the desk in the morning and explained that we had to go home -- family emergency.
It was a good time.
.
.I wish we'd have thought of that!
LOL something tells me ZLAB may be Banker's LAST stock recommendation.The gift that keeps on taking, Luckyone suggestion in now down to $21.75. Luckyone seems to have broke many of his clients.

He was never giving financial advice, he is nothing but a liar and wanna be.LOL something tells me ZLAB may be Banker's LAST stock recommendation.![]()
/—-/ It was a good short. Sorry if any of you are bag holders.Luckyone , Zlab is at $19.93, you have really honed in on a good stock.
Timberrrrrrrrrr!